Skip to main content
Erschienen in: Supportive Care in Cancer 2/2020

06.09.2019 | Review Article

Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis

verfasst von: Renata Cristina de Campos Pereira Silveira, Paula Elaine Diniz dos Reis, Elaine Barros Ferreira, Fernanda Titareli Merizio Martins Braga, Cristina Maria Galvão, Alexander Michael Clark

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify the most effective dressing for covering long-term central venous catheter exit site to prevent catheter-related infections and skin irritation in patients undergoing hematopoietic stem cell transplantation.

Methods

Systematic Review. The search was performed in the following electronic databases: CINAHL, Cochrane Library CENTRAL, EMBASE, LILACS, PubMed, Scopus, and Web of Science. Google Scholar was used for the gray literature search.

Results

Seven studies were included which tested different arrangements of dressings: sterilized gauze and adhesive tape with a transparent polyurethane film (n = 2), transparent polyurethane film with a different replacement interval frequency (n = 2), transparent polyurethane film with and without chlorhexidine released continuously by the dressing at the site of intravascular catheter insertion (n = 2), and dressings vs. no dressings (n = 1). The meta-analysis for catheter-related infection prevention showed no difference between type of dressing (RR 1.76, [95% CI 0.82; 3.75], I2 0%) and for the replacement frequency at different intervals (RR 1.04, [95% CI 0.67; 1.61], I2 0%). The meta-analysis for skin irritation evaluated the transparent polyurethane film replacement frequency and indicated that a longer dressing replacement interval (10 to 15 days) reduces the risk of developing this outcome (RR 0.71, 0.52; 0.96, 95% CI, I2 24%).

Conclusions

Regarding the type of the dressing, there is no evidence indicating the best dressing. Although there is no evidence available for the ideal replacement frequency, the risk to develop skin irritation is reduced in longer dressing replacements intervals.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R (2007) A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45:1296–1304. https://doi.org/10.1086/522533 CrossRefPubMed Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R (2007) A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45:1296–1304. https://​doi.​org/​10.​1086/​522533 CrossRefPubMed
6.
Zurück zum Zitat Hoffmann KK, Weber DJ, Samsa GP, Rutala WA (1992) Transparent polyurethane film as an intravenous catheter dressing. JAMA 267:2072–2076CrossRefPubMed Hoffmann KK, Weber DJ, Samsa GP, Rutala WA (1992) Transparent polyurethane film as an intravenous catheter dressing. JAMA 267:2072–2076CrossRefPubMed
7.
Zurück zum Zitat Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R (1999) A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 27(6):488–496CrossRefPubMed Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R (1999) A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 27(6):488–496CrossRefPubMed
11.
Zurück zum Zitat Margatho AS, Ciol MA, Hoffman JM, Dos Reis PED, Furuya RK, Lima DAFS, Basile-Filho A, Silveira RCCP (2018) Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: a pilot randomised controlled trial. Aust Crit Care S1036-7314:1–8. https://doi.org/10.1016/j.aucc.2018.11.001 CrossRef Margatho AS, Ciol MA, Hoffman JM, Dos Reis PED, Furuya RK, Lima DAFS, Basile-Filho A, Silveira RCCP (2018) Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: a pilot randomised controlled trial. Aust Crit Care S1036-7314:1–8. https://​doi.​org/​10.​1016/​j.​aucc.​2018.​11.​001 CrossRef
14.
Zurück zum Zitat Rasero L, Degl’Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G (2000) Comparison of two different protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized multicenter study. Haematologica 85:275–279 http://www.haematologica.org/content/85/3/275.full.pdf+html. Accessed May 1st, 2019 Rasero L, Degl’Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G (2000) Comparison of two different protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized multicenter study. Haematologica 85:275–279 http://​www.​haematologica.​org/​content/​85/​3/​275.​full.​pdf+html. Accessed May 1st, 2019
15.
Zurück zum Zitat Benhamou E, Fessard E, Com-Nougué C, Beaussier PS, Nitenberg G, Tancrède C, Dodeman S, Hartmann O (2002) Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomized trial. Bone Marrow Transplant 29:653–658 https://www.nature.com/articles/1703511. Accessed May 1st, 2019CrossRefPubMed Benhamou E, Fessard E, Com-Nougué C, Beaussier PS, Nitenberg G, Tancrède C, Dodeman S, Hartmann O (2002) Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomized trial. Bone Marrow Transplant 29:653–658 https://​www.​nature.​com/​articles/​1703511. Accessed May 1st, 2019CrossRefPubMed
16.
Zurück zum Zitat Vokurka S, Bystricka E, Visokaiova M, Scudlova J (2009) Once-versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. Med Sci Monit 15:CR107–CR110PubMed Vokurka S, Bystricka E, Visokaiova M, Scudlova J (2009) Once-versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. Med Sci Monit 15:CR107–CR110PubMed
21.
Zurück zum Zitat Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJ (2016) A randomized trial on chlorhexedine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 27:1916–1922. https://doi.org/10.1093/annonc/mdw275 CrossRefPubMed Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJ (2016) A randomized trial on chlorhexedine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 27:1916–1922. https://​doi.​org/​10.​1093/​annonc/​mdw275 CrossRefPubMed
22.
Zurück zum Zitat Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P (1991) A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nurs Forum 18:1349–1356PubMed Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P (1991) A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nurs Forum 18:1349–1356PubMed
23.
Zurück zum Zitat Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF (1996) Comparison of central venous catheter dressing in bone marrow transplant recipients. Oncol Nurs Forum 23:829–836PubMed Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF (1996) Comparison of central venous catheter dressing in bone marrow transplant recipients. Oncol Nurs Forum 23:829–836PubMed
24.
Zurück zum Zitat Olson K, Rennie RP, Hanson J, Ryan M, Gilpin J, Falsetti M, Heffner T, Gaudet S (2004) Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs 27:37–44CrossRefPubMed Olson K, Rennie RP, Hanson J, Ryan M, Gilpin J, Falsetti M, Heffner T, Gaudet S (2004) Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs 27:37–44CrossRefPubMed
25.
Metadaten
Titel
Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis
verfasst von
Renata Cristina de Campos Pereira Silveira
Paula Elaine Diniz dos Reis
Elaine Barros Ferreira
Fernanda Titareli Merizio Martins Braga
Cristina Maria Galvão
Alexander Michael Clark
Publikationsdatum
06.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05065-9

Weitere Artikel der Ausgabe 2/2020

Supportive Care in Cancer 2/2020 Zur Ausgabe

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.